• Je něco špatně v tomto záznamu ?

Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement

S. Reyes, AL. Cunningham, T. Kalincik, EK. Havrdová, N. Isobe, J. Pakpoor, L. Airas, RF. Bunyan, A. van der Walt, J. Oh, J. Mathews, FJ. Mateen, G. Giovannoni

. 2021 ; 357 (-) : 577627. [pub] 20210607

Jazyk angličtina Země Nizozemsko

Typ dokumentu konsensus - konference, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025120

In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025120
003      
CZ-PrNML
005      
20211026134113.0
007      
ta
008      
211013s2021 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jneuroim.2021.577627 $2 doi
035    __
$a (PubMed)34139567
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Reyes, Saúl $u Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Fundación Santa Fe de Bogotá, Bogotá, Colombia; School of Medicine, Universidad de los Andes, Bogotá, Colombia
245    10
$a Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement / $c S. Reyes, AL. Cunningham, T. Kalincik, EK. Havrdová, N. Isobe, J. Pakpoor, L. Airas, RF. Bunyan, A. van der Walt, J. Oh, J. Mathews, FJ. Mateen, G. Giovannoni
520    9_
$a In this consensus statement, we provide updated recommendations on multiple sclerosis (MS) management during the COVID-19 crisis and the post-pandemic period applicable to neurology services around the world. Statements/recommendations were generated based on available literature and the experience of 13 MS expert panelists using a modified Delphi approach online. The statements/recommendations give advice regarding implementation of telemedicine; use of disease-modifying therapies and management of MS relapses; management of people with MS at highest risk from COVID-19; management of radiological monitoring; use of remote pharmacovigilance; impact on MS research; implications for lowest income settings, and other key issues.
650    _2
$a COVID-19 $x epidemiologie $x terapie $7 D000086382
650    _2
$a management nemoci $7 D019468
650    _2
$a lidé $7 D006801
650    12
$a internacionalita $7 D038622
650    _2
$a roztroušená skleróza $x epidemiologie $x terapie $7 D009103
650    _2
$a pandemie $x prevence a kontrola $7 D058873
650    _2
$a farmakovigilance $7 D060735
650    _2
$a směrnice pro lékařskou praxi jako téma $x normy $7 D017410
650    _2
$a telemedicína $x normy $x trendy $7 D017216
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Cunningham, Anthony L $u The Westmead Institute, University of Sydney, Sydney, Australia
700    1_
$a Kalincik, Tomas $u CORe, Department of Medicine, University of Melbourne, Melbourne, Australia; Melbourne MS Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia
700    1_
$a Havrdová, Eva Kubala $u Department of Neurology and Center for Clinical Neuroscience, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Isobe, Noriko $u Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
700    1_
$a Pakpoor, Julia $u Oxford University Hospitals NHS Foundation Trust, Oxford, UK
700    1_
$a Airas, Laura $u Department of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland
700    1_
$a Bunyan, Reem F $u Department of Neurology, Neurosciences Center, King Fahd Specialist Hospital (KFSH)-Dammam, Dammam, Saudi Arabia
700    1_
$a van der Walt, Anneke $u Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia
700    1_
$a Oh, Jiwon $u Division of Neurology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
700    1_
$a Mathews, Joela $u Department of Pharmacy, Royal London Hospital, Barts Health NHS Trust, London, UK
700    1_
$a Mateen, Farrah J $u Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
700    1_
$a Giovannoni, Gavin $u Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: g.giovannoni@qmul.ac.uk
773    0_
$w MED00002834 $t Journal of neuroimmunology $x 1872-8421 $g Roč. 357, č. - (2021), s. 577627
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34139567 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026134119 $b ABA008
999    __
$a ok $b bmc $g 1714255 $s 1145627
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 357 $c - $d 577627 $e 20210607 $i 1872-8421 $m Journal of neuroimmunology $n J Neuroimmunol $x MED00002834
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

    Možnosti archivace